or Try an Advanced Search...

    Technical Analysis for TRAW - Traws Pharma, Inc.

    Grade Last Price % Change Price Change
    F 4.49 -4.47% -0.21
    TRAW closed down 4.47 percent on Wednesday, November 20, 2024, on 76 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical TRAW trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    New 52 Week Closing Low Bearish 0.00%
    New 52 Week Low Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Reached Oversold Weakness -4.47%
    Down 3 Days in a Row Weakness -4.47%
    Older End-of-Day Signals for TRAW ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 2 days ago
    Down 2 % 2 days ago
    Down 1% 2 days ago
    60 Minute Opening Range Breakout 3 days ago
    Up 2% 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TRAW Chart by TradingView
    Basic chart:

    Profile

    Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer

    Is TRAW a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 8 Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil
    Sep 30 Traws Pharma announces results from its early stage trial for its COVID candidate
    Sep 30 Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
    Sep 20 Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
    Sep 17 Traws Pharma, Inc. Announces Special Shareholders Meeting Results
    Aug 20 Traws Pharma, Inc. (TRAW) Corporate Update Call Transcript
    Aug 15 Traws Pharma GAAP EPS of -$4.87
    Aug 15 Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
    See more TRAW news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.5
    52 Week Low 4.155
    Average Volume 13,032
    200-Day Moving Average 12.60
    50-Day Moving Average 5.69
    20-Day Moving Average 5.10
    10-Day Moving Average 5.20
    Average True Range 0.40
    RSI (14) 34.21
    ADX 29.78
    +DI 16.03
    -DI 32.45
    Chandelier Exit (Long, 3 ATRs) 4.76
    Chandelier Exit (Short, 3 ATRs) 5.36
    Upper Bollinger Bands 5.74
    Lower Bollinger Band 4.47
    Percent B (%b) 0.02
    BandWidth 24.79
    MACD Line -0.19
    MACD Signal Line -0.18
    MACD Histogram -0.0069
    Fundamentals Value
    Market Cap 94.31 Million
    Num Shares 21 Million
    EPS -0.96
    Price-to-Earnings (P/E) Ratio -4.68
    Price-to-Sales 64.59
    Price-to-Book 1.01
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.31
    Resistance 3 (R3) 5.29 4.99 5.17
    Resistance 2 (R2) 4.99 4.79 5.00 5.13
    Resistance 1 (R1) 4.74 4.66 4.60 4.76 5.08
    Pivot Point 4.45 4.45 4.38 4.46 4.45
    Support 1 (S1) 4.20 4.24 4.05 4.22 3.90
    Support 2 (S2) 3.90 4.11 3.91 3.85
    Support 3 (S3) 3.65 3.90 3.81
    Support 4 (S4) 3.67